Inventor
DENG BO-LIANG
US38 patents
⚠️ This page may combine multiple inventors who share the name “DENG BO-LIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEKTAR THERAPEUTICS
26 patentsUS9233168B2Jan 12, 2016
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS7 citations92
US9233167B2Jan 12, 2016
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS7 citations92
US8952032B2Feb 10, 2015
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS9 citations92
US8946285B2Feb 3, 2015
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS9 citations92
US9512135B2Dec 6, 2016
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS4 citations84
US9458166B2Oct 4, 2016
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS4 citations84
US11744898B2Sep 5, 2023
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods
NEKTAR THERAPEUTICS2 citations71
US10189859B2Jan 29, 2019
Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
NEKTAR THERAPEUTICS2 citations70
US10143690B2Dec 4, 2018
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS1 citations63
US8895553B2Nov 25, 2014
Oligomer-containing substituted aromatic triazine compounds
NEKTAR THERAPEUTICS3 citations63
US12214045B2Feb 4, 2025
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods
NEKTAR THERAPEUTICS0 citations61
US12325708B2Jun 10, 2025
Adenosine 2 receptor antagonists
NEKTAR THERAPEUTICS0 citations59
US12054553B2Aug 6, 2024
Immunotherapeutic tumor treatment method
NEKTAR THERAPEUTICS0 citations58
US12030940B2Jul 9, 2024
Immunotherapeutic tumor treatment method
NEKTAR THERAPEUTICS0 citations55
US10512644B2Dec 24, 2019
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS0 citations52
US9827239B2Nov 28, 2017
Oligomer-opioid agonist conjugates
NEKTAR THERAPEUTICS0 citations52
US9617228B2Apr 11, 2017
Oligomer-containing substituted aromatic triazine compounds
NEKTAR THERAPEUTICS0 citations52
US9421204B2Aug 23, 2016
Oligomer modified diaromatic substituted compounds
NEKTAR THERAPEUTICS0 citations52
US9266845B2Feb 23, 2016
Oligomer-containing substituted aromatic triazine compounds
NEKTAR THERAPEUTICS0 citations52
US9233169B2Jan 12, 2016
Oligomer-bis-chromonyl compound conjugates
NEKTAR THERAPEUTICS0 citations52
US9149538B2Oct 6, 2015
Oligomer conjugates of heteropentacyclic nucleosides
NEKTAR THERAPEUTICS0 citations52
US9126926B2Sep 8, 2015
Oligomer-anticholinergic agent conjugates
NEKTAR THERAPEUTICS0 citations52
US8778898B2Jul 15, 2014
Oligomer conjugates of heteropentacyclic nucleosides
NEKTAR THERAPEUTICS0 citations52
US10766864B2Sep 8, 2020
Morphinan derivatives for the treatment of neuropathic pain
NEKTAR THERAPEUTICS0 citations50
US10844076B2Nov 24, 2020
Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
NEKTAR THERAPEUTICS0 citations49
US9132200B2Sep 15, 2015
Oligomer-calcium channel blocker conjugates
NEKTAR THERAPEUTICS0 citations48
RIGGS-SAUTHIER JENNIFER
9 patentsUS8173666B2May 8, 2012
Oligomer-opioid agonist conjugates
RIGGS-SAUTHIER JENNIFER24 citations96
US8575196B2Nov 5, 2013
Oligomer-opioid agonist conjugates
RIGGS-SAUTHIER JENNIFER18 citations92
US8569343B2Oct 29, 2013
Oligomer-opioid agonist conjugates
RIGGS-SAUTHIER JENNIFER11 citations92
US8440687B2May 14, 2013
Oligomer-opioid agonist conjugates
RIGGS-SAUTHIER JENNIFER16 citations92
US9095621B2Aug 4, 2015
Oligome-bis-chromonyl compound conjugates
RIGGS-SAUTHIER JENNIFER11 citations84
US8772479B2Jul 8, 2014
Oligomer-containing substituted aromatic triazine compounds
RIGGS-SAUTHIER JENNIFER5 citations84
US9226970B2Jan 5, 2016
Oligomer modified diaromatic substituted compounds
RIGGS-SAUTHIER JENNIFER0 citations52
US8389759B2Mar 5, 2013
Oligomer-anticholinergic agent conjugates
RIGGS-SAUTHIER JENNIFER1 citations52
US9090535B2Jul 28, 2015
Hydroxylated tricyclic compounds
RIGGS-SAUTHIER JENNIFER0 citations51